AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2026
Mar 4, 2026
29755_dirs_2026-03-03_555a22bd-6857-4d6c-b583-6c38e952f34d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2026-02-27
Reporting Person: Purdue David Ryan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Common Stock, $0.01 par value | F | 2692 | $232.08 | Disposed | 7884 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 543 | Indirect |
Footnotes
F1: Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
More from AbbVie Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4